Thus, this study demonstrated that vaccination of thimerosal-sensitized individuals may be considered when the benefits outweigh the risks of these local reactions. In a retrospective case-control ...

All reactions were reported at the time of ... being the main vaccine implicated (seven cases), followed by meningococcal C vaccine (four cases).

Meningococcal disease is a serious bacterial infection caused by Neisseria meningitidis, which can lead to severe health complications, including meningitis and septicemia. Vaccination plays a ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

and life-threatening meningococcal conditions, such as meningitis. Most people can safely get the vaccine with no or minor ...

Morehead State University provides this information about Meningococcal meningitis disease consistent with the Centers for Disease Control guidelines to all freshmen and students living in resident ...

Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years.

or who have previously received only one dose of vaccine One dose annually for all children 9 years or older Meningococcal vaccine, to protect against four types of meningococcal bacteria ...